3 blue chip shares that smashed the ASX 200 index in FY21

We take a look at 3 growth shares that outperformed the ASX 200 index in the 2021 financial year.

| More on:
Three shareholders climbing ladders up into the clouds

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

FY21 has been a positive year for blue chip shares with the S&P/ASX 200 Index (ASX: XJO) rising 20.44%. A great result compared to this time last year when the ASX 200 had plummeted 11 per cent amid the economic impacts of COVID-19.

The index is the benchmark for Australian equity performance as it lists the 200 largest ASX stocks. We take a look at 3 ASX 200 stocks that were growth outliers in FY21.

Netwealth Group Ltd (ASX: NWL)

In the past 12 months, the Netwealth share price has shot up more than 76%. As well as more than tripling the ASX 200 index increase, the company has also exceeded the Australian Capital Markets industry which returned 20.8% over the past year.

It seems Netwealth has been riding the perfect storm. In its half-yearly report, the financial services company increased its funds under administration (FUA) for the half by $7.3 billion, or around 23%, taking its total FUA as at 31 December 2020 to $38.8 billion.

In April, Netwealth released its third-quarter update which showed Netwealth's FUA had reached $41.8 billion. An increase of $3 billion or 7.8% since the end of December, including a positive market movement of $0.8 billion.

As of 29 June, investment company BlackRock put the average price-to-earnings (P/E) ratio across the ASX 200 at 24.47. Netwealth's P/E ratio currently sits at 78.53. The Netwealth share price was trading at $16.75 at market close on Thursday.

Goodman Group (ASX: GMG)

The Goodman Group share price increased 34.3% over the past 12 months. The property group also performed well when compared to the real estate investment trust (REIT) industry which returned 24% over the same time.

Goodman is a property services group with a $39 billion market cap. In its half-year results for the six months ended 31 December, the company reported a 16% increase in operating profit to $614.9 million. In addition, demand for its properties were so strong, that the company leased an additional 1.9 million square metres. 

Goodman ended the third quarter on a positive note, its earnings results for that period showing a net property income increase of 3.3% and an occupancy rate standing at 98%.

Goodman's P/E ratio currently stands at 22.4 which appears a fair value compared to the index. The Goodman share price closed at $21 on Thursday.

Sonic Healthcare Limited (ASX: SHL)

Sonic Healthcare was another top performer in FY21, returning a solid 24% lift over the last 12 months. This beats the ASX 200 index as well as the Australian healthcare industry which increased over the same period by 18%.

Sonic Healthcare is a global pathology and medical imaging provider. In February, Sonic's half-yearly report was full of positive news including revenue growth of 33% to $4.4 billion, earnings before interest, tax, depreciation and amortisation (EBITDA) growth of 89% to A$1.3 billion and net profit growth of 166% to $678 million.

In June, Sonic took a significant step, by acquiring the Canberra Imaging Group (CIG). The company called this "a positive step" in the development of its imaging division in Australia.

On 30 June, Sonic shares hit an all-time high of $38.51. Despite the growth, Sonic Healthcare is still well-priced according to its P/E ratio of around 19.

The Sonic share price was trading at $38.08 at Thursday's market close.

Motley Fool contributor Frank Tzimas has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended Netwealth. The Motley Fool Australia owns shares of and has recommended Netwealth. The Motley Fool Australia has recommended Sonic Healthcare Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Blue Chip Shares

2 women looking at phone
Blue Chip Shares

3 high quality blue chip ASX 200 shares to buy in November

Here are a few blue chip shares that have been rated as buys this month by analysts.

Read more »

A businessman lights up the fifth star in a lineup, indicating positive share price for a top performer
Blue Chip Shares

2 of the highest-quality blue chip ASX 200 stocks money can buy

Analysts think these blue chips are top buys for investors right now. But why?

Read more »

Three smiling corporate people examine a model of a new building complex.
Blue Chip Shares

This blue chip ASX 200 stock is 'among the highest-quality names' under coverage

Goldman Sachs thinks this blue chip is a top buy.

Read more »

A business woman flexes her muscles overlooking a city scape below.
Blue Chip Shares

Brokers name 2 strong ASX 200 shares to buy now

These shares are among the top picks on the benchmark ASX 200 index according to analysts.

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
Blue Chip Shares

Up 47% in a year: This blue chip ASX 200 stock can keep rising

Bell Potter is feeling bullish about this stock. But why?

Read more »

A man looking at his laptop and thinking.
Blue Chip Shares

Should you buy Coles and Mineral Resources shares this month?

Are these blue chips buys? Let's see what Bell Potter is saying about them.

Read more »

Happy man working on his laptop.
Blue Chip Shares

These big ASX 200 blue chip shares could rise 20% to 50%

Analysts think these blue chips could be cheap at current levels.

Read more »

A man holding a cup of coffee puts his thumb up and smiles while at laptop.
Blue Chip Shares

Why this ASX 200 share is one of the 'highest-quality names'

Goldman Sachs is a huge fan of this blue chip. But why?

Read more »